Serum Institute  

‘We are pleased to inform that in the month of June we will be able to manufacture and supply nine to 10 crore doses of our Covishield vaccine to the country as compared to our production capacity of 6.5 crore doses in May,’ Prakash Kumar Singh, the Director of Government and Regulatory Affairs at SII, said in the letter
 

With the Serum Institute, India is blessed to have a major manufacturer of global vaccines and he is encouraged by the country’s ramping up of its domestic vaccination programme, said World Bank President David Malpass
 

Anita Anand, the Canadian minister of public services and procurement, received the first tranche of 500,000 doses of Serum Institute of India's Covishield

UNICEF has entered into an agreement with Serum Institute of India for supply of Astra Zeneca/Oxford and Novavax vaccines

India has decided to export life-saving vaccine to Pakistan, as part of global Covax alliance

While India continues to export corona vaccines to the rest of the world, Serum Institute India chief Adar Poonawalla has announced that the company may launch a second coronavirus vaccine in June this year

From Sri Lanka to Bahrain, India, the vaccine pharmacy of the world has gifted several doses of vaccines to different countries
 

In a glowing tribute to India’s vaccine manufacturing prowess, United Nations Secretary-General Antonio Guterres termed it the 'best asset' of the world
 

India has registered more than 1 million vaccinations within the first six days of the mega drive, becoming the fastest country to do so
 

India will be exporting 3 million doses of AstraZeneca vaccine to Saudi Arabia in about a week or ten days on behalf of the British pharmaceutical major which is facing production issues at its own factory in Belgium

Covishield uses a replication-deficient chimpanzee viral vector based on a modified adenovirus virus (which causes the common cold) that contains genetic material from the SARS-CoV-2 virus. Vaccine dosage enables the immune system to attack the Covid-19 virus if it infects the body
 

The Serum Institute of India has come out with a new Pneumococcal Conjugate Vaccine, which it claims counters bacteria that can cause illnesses like pneumonia, which
causes infection of the lungs

Serum Institute of India (SII) is all set to expand its manufacturing of Covishield vaccine
 

India manufactures more than 60% of all vaccines sold across the globe, and while its $40 billion pharmaceutical sector is not yet involved in the production of the expensive Pfizer Inc and Moderna shots, the nation will play a pivotal role in immunizing much of the world

Serum Institute of India's CEO Adar Poonawalla has been named among six people as "Asians of the Year" by Singapore's leading daily, The Straits Times